Global Plasma Protease C1-inhibitor Treatment Market Research Report 2023

Report ID: 1983883 | Published Date: Jan 2025 | No. of Page: 60 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 C1-inhibitors
        1.2.3 Kallikrein Inhibitor (Kalbitor)
    1.3 Market by Application
        1.3.1 Global Plasma Protease C1-inhibitor Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Independent Pharmacies and Outlets
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Plasma Protease C1-inhibitor Treatment Market Perspective (2017-2028)
    2.2 Plasma Protease C1-inhibitor Treatment Growth Trends by Region
        2.2.1 Plasma Protease C1-inhibitor Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Plasma Protease C1-inhibitor Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Plasma Protease C1-inhibitor Treatment Market Dynamics
        2.3.1 Plasma Protease C1-inhibitor Treatment Industry Trends
        2.3.2 Plasma Protease C1-inhibitor Treatment Market Drivers
        2.3.3 Plasma Protease C1-inhibitor Treatment Market Challenges
        2.3.4 Plasma Protease C1-inhibitor Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Plasma Protease C1-inhibitor Treatment Players by Revenue
        3.1.1 Global Top Plasma Protease C1-inhibitor Treatment Players by Revenue (2017-2022)
        3.1.2 Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Plasma Protease C1-inhibitor Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Plasma Protease C1-inhibitor Treatment Revenue
    3.4 Global Plasma Protease C1-inhibitor Treatment Market Concentration Ratio
        3.4.1 Global Plasma Protease C1-inhibitor Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Plasma Protease C1-inhibitor Treatment Revenue in 2021
    3.5 Plasma Protease C1-inhibitor Treatment Key Players Head office and Area Served
    3.6 Key Players Plasma Protease C1-inhibitor Treatment Product Solution and Service
    3.7 Date of Enter into Plasma Protease C1-inhibitor Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Plasma Protease C1-inhibitor Treatment Breakdown Data by Type
    4.1 Global Plasma Protease C1-inhibitor Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Type (2023-2028)
5 Plasma Protease C1-inhibitor Treatment Breakdown Data by Application
    5.1 Global Plasma Protease C1-inhibitor Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Plasma Protease C1-inhibitor Treatment Market Size (2017-2028)
    6.2 North America Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022)
    6.3 North America Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Plasma Protease C1-inhibitor Treatment Market Size (2017-2028)
    7.2 Europe Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022)
    7.3 Europe Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Plasma Protease C1-inhibitor Treatment Market Size (2017-2028)
    9.2 Latin America Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022)
    9.3 Latin America Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Takeda
        11.1.1 Takeda Company Detail
        11.1.2 Takeda Business Overview
        11.1.3 Takeda Plasma Protease C1-inhibitor Treatment Introduction
        11.1.4 Takeda Revenue in Plasma Protease C1-inhibitor Treatment Business (2017-2022)
        11.1.5 Takeda Recent Development
    11.2 CSL
        11.2.1 CSL Company Detail
        11.2.2 CSL Business Overview
        11.2.3 CSL Plasma Protease C1-inhibitor Treatment Introduction
        11.2.4 CSL Revenue in Plasma Protease C1-inhibitor Treatment Business (2017-2022)
        11.2.5 CSL Recent Development
    11.3 Sanquin
        11.3.1 Sanquin Company Detail
        11.3.2 Sanquin Business Overview
        11.3.3 Sanquin Plasma Protease C1-inhibitor Treatment Introduction
        11.3.4 Sanquin Revenue in Plasma Protease C1-inhibitor Treatment Business (2017-2022)
        11.3.5 Sanquin Recent Development
    11.4 Pharming Group
        11.4.1 Pharming Group Company Detail
        11.4.2 Pharming Group Business Overview
        11.4.3 Pharming Group Plasma Protease C1-inhibitor Treatment Introduction
        11.4.4 Pharming Group Revenue in Plasma Protease C1-inhibitor Treatment Business (2017-2022)
        11.4.5 Pharming Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of C1-inhibitors
    Table 3. Key Players of Kallikrein Inhibitor (Kalbitor)
    Table 4. Global Plasma Protease C1-inhibitor Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Plasma Protease C1-inhibitor Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Plasma Protease C1-inhibitor Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Plasma Protease C1-inhibitor Treatment Market Share by Region (2017-2022)
    Table 8. Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Plasma Protease C1-inhibitor Treatment Market Share by Region (2023-2028)
    Table 10. Plasma Protease C1-inhibitor Treatment Market Trends
    Table 11. Plasma Protease C1-inhibitor Treatment Market Drivers
    Table 12. Plasma Protease C1-inhibitor Treatment Market Challenges
    Table 13. Plasma Protease C1-inhibitor Treatment Market Restraints
    Table 14. Global Plasma Protease C1-inhibitor Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Plasma Protease C1-inhibitor Treatment Market Share by Players (2017-2022)
    Table 16. Global Top Plasma Protease C1-inhibitor Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Protease C1-inhibitor Treatment as of 2021)
    Table 17. Ranking of Global Top Plasma Protease C1-inhibitor Treatment Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Plasma Protease C1-inhibitor Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Plasma Protease C1-inhibitor Treatment Product Solution and Service
    Table 21. Date of Enter into Plasma Protease C1-inhibitor Treatment Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Plasma Protease C1-inhibitor Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Type (2017-2022)
    Table 25. Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Type (2023-2028)
    Table 27. Global Plasma Protease C1-inhibitor Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Application (2017-2022)
    Table 29. Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Application (2023-2028)
    Table 31. North America Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Takeda Company Detail
    Table 42. Takeda Business Overview
    Table 43. Takeda Plasma Protease C1-inhibitor Treatment Product
    Table 44. Takeda Revenue in Plasma Protease C1-inhibitor Treatment Business (2017-2022) & (US$ Million)
    Table 45. Takeda Recent Development
    Table 46. CSL Company Detail
    Table 47. CSL Business Overview
    Table 48. CSL Plasma Protease C1-inhibitor Treatment Product
    Table 49. CSL Revenue in Plasma Protease C1-inhibitor Treatment Business (2017-2022) & (US$ Million)
    Table 50. CSL Recent Development
    Table 51. Sanquin Company Detail
    Table 52. Sanquin Business Overview
    Table 53. Sanquin Plasma Protease C1-inhibitor Treatment Product
    Table 54. Sanquin Revenue in Plasma Protease C1-inhibitor Treatment Business (2017-2022) & (US$ Million)
    Table 55. Sanquin Recent Development
    Table 56. Pharming Group Company Detail
    Table 57. Pharming Group Business Overview
    Table 58. Pharming Group Plasma Protease C1-inhibitor Treatment Product
    Table 59. Pharming Group Revenue in Plasma Protease C1-inhibitor Treatment Business (2017-2022) & (US$ Million)
    Table 60. Pharming Group Recent Development
    Table 61. Research Programs/Design for This Report
    Table 62. Key Data Information from Secondary Sources
    Table 63. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Plasma Protease C1-inhibitor Treatment Market Share by Type: 2021 VS 2028
    Figure 2. C1-inhibitors Features
    Figure 3. Kallikrein Inhibitor (Kalbitor) Features
    Figure 4. Global Plasma Protease C1-inhibitor Treatment Market Share by Application in 2021 & 2028
    Figure 5. Hospital Pharmacies Case Studies
    Figure 6. Independent Pharmacies and Outlets Case Studies
    Figure 7. Plasma Protease C1-inhibitor Treatment Report Years Considered
    Figure 8. Global Plasma Protease C1-inhibitor Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 9. Global Plasma Protease C1-inhibitor Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Plasma Protease C1-inhibitor Treatment Market Share by Region: 2021 VS 2028
    Figure 11. Global Plasma Protease C1-inhibitor Treatment Market Share by Players in 2021
    Figure 12. Global Top Plasma Protease C1-inhibitor Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Protease C1-inhibitor Treatment as of 2021)
    Figure 13. The Top 10 and 5 Players Market Share by Plasma Protease C1-inhibitor Treatment Revenue in 2021
    Figure 14. North America Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 15. North America Plasma Protease C1-inhibitor Treatment Market Share by Country (2017-2028)
    Figure 16. United States Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. Canada Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Europe Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Plasma Protease C1-inhibitor Treatment Market Share by Country (2017-2028)
    Figure 20. Germany Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. France Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. U.K. Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Italy Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Russia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Nordic Countries Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Share by Region (2017-2028)
    Figure 28. China Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Japan Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. South Korea Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. India Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Australia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Latin America Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Plasma Protease C1-inhibitor Treatment Market Share by Country (2017-2028)
    Figure 36. Mexico Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Brazil Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Share by Country (2017-2028)
    Figure 40. Turkey Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Saudi Arabia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Takeda Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2017-2022)
    Figure 43. CSL Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2017-2022)
    Figure 44. Sanquin Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2017-2022)
    Figure 45. Pharming Group Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2017-2022)
    Figure 46. Bottom-up and Top-down Approaches for This Report
    Figure 47. Data Triangulation
    Figure 48. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Takeda
CSL
Sanquin
Pharming Group
Frequently Asked Questions
Plasma Protease C1-inhibitor Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Plasma Protease C1-inhibitor Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Plasma Protease C1-inhibitor Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Ureteroscopes

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Underfill Materials

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More